Answer
Women should not breastfeed during avelumab treatment and for at least 1 month after the last dose because of the potential for serious adverse reactions in breastfed infants.
Sources for this answer
- Bavencio 20 mg/mL concentrate for solution for infusionMerck · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 20Document updated
Sources checked